新型冠状病毒病2019与院外心脏骤停:无存活者
该研究为观察性研究,基于法国全国院外心脏骤停登记系统,纳入2020年3月至12月95个移动ICU收治的6624例院外心脏骤停患者,其中确诊COVID-19 127例、疑似473例、阴性6024例。确诊和疑似组呼吸性病因骤停比例相似(53.7% vs 56.5%),均高于阴性组(14.0%)。确诊组高级生命支持启动率57.5%,低于阴性组70.6%。确诊组30天存活率为0%,疑似组0.9%,阴性组3.5%。结论提示确诊COVID-19的院外心脏骤停患者存活率为零,对复苏的无用性及风险管理提出重要问题。
要点
- 确诊COVID-19的院外心脏骤停患者30天存活率为0%(127例),疑似组0.9%(473例),阴性组3.5%(6024例)。
- 确诊和疑似COVID-19患者呼吸性病因骤停比例分别为53.7%和56.5%,显著高于阴性组的14.0%。
- 确诊组高级生命支持启动率为57.5%,低于疑似组64.5%和阴性组70.6%(确诊vs阴性p=0.002)。
- 确诊与疑似COVID-19组患者特征相似,疑似组与确诊组30天存活率差异无统计学意义(p=0.583)。
- 研究结果引发对COVID-19患者复苏无用性及医务人员风险管理的重要思考。
适用人群与场景
- 法国2020年3月至12月院外心脏骤停患者,由95个移动ICU收集数据,包括确诊COVID-19 127例、疑似473例、阴性6024例。
- COVID-19状态根据世界卫生组织标准定义(确诊、疑似或阴性)。
诊断标准与关键阈值
- COVID-19状态根据世界卫生组织标准分为确诊、疑似或阴性。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:观察性研究;样本量:6624例院外心脏骤停患者;中心数:95个移动ICU。
- 人群:确诊COVID-19 127例,疑似473例,阴性6024例;干预:无;对照:按COVID-19状态分组比较。
- 主要终点:30天存活率确诊组0%(127例),疑似组0.9%(473例,vs确诊p=0.583),阴性组3.5%(6024例,vs确诊p=0.023)。
- 关键次要终点:呼吸性病因骤停比例确诊组53.7%,疑似组56.5%(vs确诊p=0.472),阴性组14.0%(vs确诊p<0.001)。
- 高级生命支持启动率:确诊组57.5%,疑似组64.5%(vs确诊p=0.149),阴性组70.6%(vs确诊p=0.002)。
证据类型、等级与局限
- 证据类型:观察性研究(基于法国国家院外心脏骤停登记系统)。
- 局限:原文未明确提及证据等级;设计为观察性研究,非随机对照,可能存在混杂因素。
对床旁实践的改变
- 对于确诊COVID-19的院外心脏骤停患者,30天存活率为0%,提示复苏可能无效,需结合临床情况考虑复苏决策。
- 确诊和疑似COVID-19患者呼吸性病因骤停比例高,应关注呼吸道管理及防护。
- 确诊COVID-19患者高级生命支持启动率较低,可能与复苏决策或资源分配有关。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe and compare survival among patients with out-of-hospital cardiac arrest as a function of their status for coronavirus disease 2019.
DESIGN: We performed an observational study of out-of-hospital cardiac arrest patients between March 2020 and December 2020. Coronavirus disease 2019 status (confirmed, suspected, or negative) was defined according to the World Health Organization's criteria.
SETTING: Information on the patients and their care was extracted from the French national out-of-hospital cardiac arrest registry. The French prehospital emergency medical system has two tiers: the fire department intervenes rapidly to provide basic life support, and mobile ICUs provide advanced life support. The study data (including each patient's coronavirus disease 2019 status) were collected by 95 mobile ICUs throughout France.
PATIENTS: We included 6,624 out-of-hospital cardiac arrest patients: 127 cases with confirmed coronavirus disease 2019, 473 with suspected coronavirus disease 2019, and 6,024 negative for coronavirus disease 2019.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The "confirmed" and "suspected" groups of coronavirus disease 2019 patients had similar characteristics and were more likely to have suffered an out-of-hospital cardiac arrest with a respiratory cause (confirmed: 53.7%, suspected coronavirus disease 2019: 56.5%; p = 0.472) than noncoronavirus disease 2019 patients (14.0%; p < 0.001 vs confirmed coronavirus disease 2019 patients). Advanced life support was initiated for 57.5% of the confirmed coronavirus disease 2019 patients, compared with 64.5% of the suspected coronavirus disease 2019 patients (p = 0.149) and 70.6% of the noncoronavirus disease 2019 ones (p = 0.002). The survival rate at 30-day postout-of-hospital cardiac arrest was 0% in the confirmed coronavirus disease 2019 group, 0.9% in the suspected coronavirus disease 2019 group (p = 0.583 vs confirmed), and 3.5% (p = 0.023) in the noncoronavirus disease 2019 group.
CONCLUSIONS: Our results highlighted a zero survival rate in out-of-hospital cardiac arrest patients with confirmed coronavirus disease 2019. This finding raises important questions with regard to the futility of resuscitation for coronavirus disease 2019 patients and the management of the associated risks.
参考来源
- Baert V, Beuscart JB, Recher M, et al. Coronavirus Disease 2019 and Out-of-Hospital Cardiac Arrest: No Survivors. Crit Care Med. 2021. PMID: 34605777. doi:10.1097/CCM.0000000000005374
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。